Exploring the Cancer-Preventing Potential of GLP-1 Receptor Agonists

This chapter explores an observational study that investigates the impact of GLP-1 receptor agonists on obesity-related cancers in over 170,000 adults with obesity and diabetes. It highlights significant findings regarding colorectal cancer reduction and questions the role of weight loss versus the direct anti-cancer effects of the medications.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app